{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:46:08Z","timestamp":1785415568879,"version":"3.56.0"},"reference-count":229,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2025SF053"],"award-info":[{"award-number":["2025SF053"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2025SF053"],"award-info":[{"award-number":["2025SF053"]}],"id":[{"id":"https:\/\/ror.org\/02z1vqm45","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Pancreatic cancer ranks among the most lethal malignancies, characterized by a five-year survival rate of approximately 10%. This dismal prognosis is largely attributable to diagnoses occurring at advanced stages and the inherent limitations of conventional imaging modalities in detecting early lesions, identifying metastases, and assessing tumor heterogeneity. Consequently, there is a critical need for non-invasive imaging techniques capable of visualizing pancreatic cancer lesions to enable accurate diagnosis, risk assessment, and the development of personalized treatment strategies. Molecular imaging, which combines highly specific targeted probes with advanced imaging technologies, offers the potential to elucidate disease-associated pathways. This review provides a comprehensive overview of recent advancements in molecular imaging platforms for pancreatic cancer, including positron emission tomography (PET), single-photon emission computed tomography (SPECT), optical molecular imaging, photoacoustic imaging, and molecular MRI. We begin by elucidating the biological rationale for targeting key molecules, including fibroblast activation protein (FAP), integrins, and programmed death ligand 1 (PD-L1). Moreover, we critically evaluate the development and clinical translation of these probes, highlighting their ability to enhance lesion detectability, characterize intratumoral heterogeneity, and guide both targeted therapy and surgical resection. Compared with existing reviews, this work uniquely integrates a comprehensive cross-modality analysis of the latest molecular imaging strategies for pancreatic cancer. Furthermore, we examine prevailing challenges and emerging frontiers in this domain, specifically focusing on multimodal hybrid imaging, artificial intelligence-driven analytics, and integrated theranostic platforms as pivotal strategies to advance precision oncology.<\/jats:p>","DOI":"10.3390\/ph19071078","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:55:21Z","timestamp":1783990521000},"page":"1078","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Imaging in Pancreatic Cancer: Current Applications and Future Perspectives"],"prefix":"10.3390","volume":"19","author":[{"given":"Yongshun","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Medical Imaging, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaonan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Geriatric Hospital of Nanjing Medical University (Jiangsu Province Official Hospital), Nanjing 210024, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic Cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/cac2.12399","article-title":"Standard Pancreatoduodenectomy versus Extended Pancreatoduodenectomy with Modified Retroperitoneal Nerve Resection in Patients with Pancreatic Head Cancer: A Multicenter Randomized Controlled Trial","volume":"43","author":"Lin","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_3","first-page":"12","article-title":"Cancer Statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the Epidemiology of Pancreatic Cancer: Trends, Risk Factors, Screening, and Prognosis","volume":"520","author":"Cai","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/SLA.0000000000000384","article-title":"A Prospective Randomized Controlled Study Comparing Outcomes of Standard Resection and Extended Resection, Including Dissection of the Nerve Plexus and Various Lymph Nodes, in Patients with Pancreatic Head Cancer","volume":"259","author":"Jang","year":"2014","journal-title":"Ann. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrclinonc.2009.236","article-title":"Advanced Pancreatic Carcinoma: Current Treatment and Future Challenges","volume":"7","author":"Stathis","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1245\/s10434-009-0670-7","article-title":"Resectable Pancreatic Cancer: Who Really Benefits from Resection?","volume":"16","author":"Barugola","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MPA.0000000000001075","article-title":"Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer","volume":"47","author":"Tummers","year":"2018","journal-title":"Pancreas"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2013.01.076","article-title":"Technologies for Imaging the Normal and Diseased Pancreas","volume":"144","author":"Smith","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2967\/jnumed.112.107466","article-title":"Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic 18F-FDG PET\/CT","volume":"54","author":"Epelbaum","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2967\/jnumed.113.131847","article-title":"Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET\/CT in Patients with Pancreatic Cancer","volume":"55","author":"Lee","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.mpa.0000168226.36085.58","article-title":"Intense PET Signal in the Degenerative Necrosis Superimposed on Chronic Pancreatitis","volume":"31","author":"Yokoyama","year":"2005","journal-title":"Pancreas"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1021\/acs.bioconjchem.0c00044","article-title":"Molecular Imaging","volume":"31","author":"Zheng","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the Diagnosis of Primary and Metastatic Lesions in Patients with Various Types of Cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1021\/acs.analchem.4c00922","article-title":"NIR Fluorescent\/Photoacoustic Bimodal Imaging of Ferroptosis in Pancreatic Cancer Using Biothiols-Activable Probes","volume":"96","author":"Li","year":"2024","journal-title":"Anal. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1021\/acs.molpharmaceut.4c01368","article-title":"64Cu Radiolabeled PDGFR\u03b2-Targeting Affibody for PET Imaging in Pancreatic Cancer","volume":"22","author":"Li","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1021\/acs.molpharmaceut.5c00542","article-title":"pH\/GSH Dual-Responsive Janus-Type Au@H-MP@DOX MR Molecular Imaging Nanomotor for Combined Photothermal\/Chemotherapeutic Treatment of Pancreatic Cancer","volume":"22","author":"Zhang","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.7150\/thno.100116","article-title":"Collagen Type I PET\/MRI Enables Evaluation of Treatment Response in Pancreatic Cancer in Pre-Clinical and First-in-Human Translational Studies","volume":"14","author":"Esfahani","year":"2024","journal-title":"Theranostics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cgh.2006.02.020","article-title":"Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: A systematic review","volume":"4","author":"Dewitt","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0720-048X(01)00295-9","article-title":"Radiologic Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma","volume":"38","author":"Balci","year":"2001","journal-title":"Eur. J. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1067\/mge.2003.298","article-title":"Interobserver Agreement among Endosonographers for the Diagnosis of Neoplastic versus Non-Neoplastic Pancreatic Cystic Lesions","volume":"58","author":"Ahmad","year":"2003","journal-title":"Gastrointest. Endosc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-141-10-200411160-00006","article-title":"Comparison of Endoscopic Ultrasonography and Multidetector Computed Tomography for Detecting and Staging Pancreatic Cancer","volume":"141","author":"DeWitt","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"ref_23","first-page":"49","article-title":"Intraoperative Ultrasonography of the Pancreas: Techniques and Clinical Applications","volume":"6","author":"Kruskal","year":"1997","journal-title":"Surg. Technol. Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/RUQ.0b013e3181901ce4","article-title":"Intraoperative ultrasound of the pancreas","volume":"25","author":"Shin","year":"2009","journal-title":"Ultrasound. Q."},{"key":"ref_25","first-page":"1935","article-title":"Intraoperative Ultrasonography of the Pancreas","volume":"30","author":"Sun","year":"2010","journal-title":"Radiol. Soc. N. Am."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2013.08.008","article-title":"Molecular Imaging in Pancreatic Cancer--a Roadmap for Therapeutic Decisions","volume":"341","author":"Gore","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00464-004-8712-5","article-title":"Does Multidetector-Row CT Eliminate the Role of Diagnostic Laparoscopy in Assessing the Resectability of Pancreatic Head Adenocarcinoma?","volume":"19","author":"Ellsmere","year":"2005","journal-title":"Surg. Endosc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1148\/radiol.2453061795","article-title":"Pancreatic Adenocarcinoma: Value of Multidetector CT Angiography in Preoperative Evaluation","volume":"245","author":"Zamboni","year":"2007","journal-title":"Radiology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1148\/radiol.2243011284","article-title":"Isoattenuating Pancreatic Adenocarcinoma at Multi-Detector Row CT: Secondary Signs","volume":"224","author":"Prokesch","year":"2002","journal-title":"Radiology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/SLA.0b013e3181b2fafa","article-title":"A Prospective Diagnostic Accuracy Study of 18F-Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Diagnosis and Staging of Pancreatic Cancer","volume":"250","author":"Kauhanen","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.rct.0000164513.23407.b3","article-title":"Ultrasonography, Computed Tomography and Magnetic Resonance Imaging for Diagnosis and Determining Resectability of Pancreatic Adenocarcinoma: A Meta-Analysis","volume":"29","author":"Bipat","year":"2005","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(00)02479-X","article-title":"Pancreatic Cancer Detection with Magnetic Resonance Cholangiopancreatography and Endoscopic Retrograde Cholangiopancreatography: A Prospective Controlled Study","volume":"356","author":"Adamek","year":"2000","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11307-018-1273-0","article-title":"Paradigms in Fluorescence Molecular Imaging: Maximizing Measurement of Biological Changes in Disease, Therapeutic Efficacy, and Toxicology\/Safety","volume":"21","author":"Peterson","year":"2019","journal-title":"Mol. Imaging Biol."},{"key":"ref_34","first-page":"1S","article-title":"A Tabulated Summary of the FDG PET Literature","volume":"42","author":"Gambhir","year":"2001","journal-title":"J. Nucl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22070","article-title":"PET-PANC: Multicentre Prospective Diagnostic Accuracy and Health Economic Analysis Study of the Impact of Combined Modality 18fluorine-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography with Computed Tomography Scanning in the Diagnosis and Management of Pancreatic Cancer","volume":"22","author":"Ghaneh","year":"2018","journal-title":"Health Technol. Assess."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.crad.2015.03.010","article-title":"FDG PET\/CT in infection and inflammation--current and emerging clinical applications","volume":"70","author":"Vaidyanathan","year":"2015","journal-title":"Clin. Radiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.semnuclmed.2022.01.004","article-title":"Recent Developments in SPECT\/CT","volume":"52","author":"Ritt","year":"2022","journal-title":"Semin. Nucl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrclinonc.2012.188","article-title":"Is There Still a Role for SPECT-CT in Oncology in the PET-CT Era?","volume":"9","author":"Hicks","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1007\/s00259-022-05894-7","article-title":"Optical Molecular Imaging and Theranostics in Neurological Diseases Based on Aggregation-Induced Emission Luminogens","volume":"49","author":"Cen","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wei, J., Liu, C., Liang, W., Yang, X., and Han, S. (2023). Advances in Optical Molecular Imaging for Neural Visualization. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1250594"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s00259-022-05730-y","article-title":"Intraoperative Fluorescence Molecular Imaging Accelerates the Coming of Precision Surgery in China","volume":"49","author":"Zhang","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1002\/bjs.9713","article-title":"Optical Innovations in Surgery","volume":"102","author":"Harlaar","year":"2015","journal-title":"Br. J. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1158\/0008-5472.CAN-13-2387","article-title":"Light In and Sound Out: Emerging Translational Strategies for Photoacoustic Imaging","volume":"74","author":"Zackrisson","year":"2014","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrclinonc.2013.123","article-title":"Image-Guided Cancer Surgery Using near-Infrared Fluorescence","volume":"10","author":"Vahrmeijer","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e70020","DOI":"10.1002\/cbf.70020","article-title":"Harnessing Bioluminescence: A Comprehensive Review of In Vivo Imaging for Disease Monitoring and Therapeutic Intervention","volume":"42","author":"Sangeetha","year":"2024","journal-title":"Cell Biochem. Funct."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1109\/RBME.2020.2995124","article-title":"Bioluminescence Imaging Applications in Cancer: A Comprehensive Review","volume":"14","author":"Alsawaftah","year":"2021","journal-title":"IEEE Rev. Biomed. Eng."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nnano.2009.326","article-title":"Bioimaging: Second Window for In Vivo Imaging","volume":"4","author":"Smith","year":"2009","journal-title":"Nat. Nanotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Vladimirov, N., and Perlman, O. (2023). Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043151"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11604-025-01732-6","article-title":"Advances in Multimodal Imaging for Adrenal Gland Disorders: Integrating CT, MRI, and Nuclear Medicine","volume":"43","author":"Yokoyama","year":"2025","journal-title":"Jpn. J. Radiol."},{"key":"ref_50","first-page":"5053","article-title":"A MSLN-Targeted Multifunctional Nanoimmunoliposome for MRI and Targeting Therapy in Pancreatic Cancer","volume":"7","author":"Deng","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2967\/jnumed.112.115568","article-title":"Acoustic and Photoacoustic Molecular Imaging of Cancer","volume":"54","author":"Wilson","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nmeth.3929","article-title":"Contrast agents for molecular photoacoustic imaging","volume":"13","author":"Weber","year":"2016","journal-title":"Nat. Methods."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/smll.201302924","article-title":"In Vivo Volumetric Photoacoustic Molecular Angiography and Therapeutic Monitoring with Targeted Plasmonic Nanostars","volume":"10","author":"Nie","year":"2014","journal-title":"Small"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1118\/1.3497677","article-title":"Photoacoustic Angiography of the Breast","volume":"37","author":"Kruger","year":"2010","journal-title":"Med. Phys."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1152\/physrev.00049.2010","article-title":"A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications","volume":"92","author":"James","year":"2012","journal-title":"Physiol. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/11531280-000000000-00000","article-title":"Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies","volume":"49","author":"Keizer","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"ref_57","first-page":"79","article-title":"Recent Advances in Gene Change of Pancreatic Cancer","volume":"26","author":"Wang","year":"2004","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc2899","article-title":"KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma","volume":"10","author":"Morris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"46717","DOI":"10.18632\/oncotarget.8773","article-title":"Kirsten Ras* Oncogene: Significance of Its Discovery in Human Cancer Research","volume":"7","author":"Tsuchida","year":"2016","journal-title":"Oncotarget"},{"key":"ref_61","first-page":"re13","article-title":"Human RAS Superfamily Proteins and Related GTPases","volume":"2004","author":"Colicelli","year":"2004","journal-title":"Sci. STKE Signal Transduct. Knowl. Environ."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS Mutation in Pancreatic Cancer","volume":"48","author":"Luo","year":"2021","journal-title":"Semin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cell.2017.07.005","article-title":"Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening","volume":"170","author":"McDonald","year":"2017","journal-title":"Cell"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.12703\/r\/9-31","article-title":"Recent Advances in PTEN Signalling Axes in Cancer","volume":"9","author":"Chow","year":"2020","journal-title":"Fac. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccr.2012.10.025","article-title":"Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma","volume":"22","author":"Kopp","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF Gene in Human Cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/ncomms7744","article-title":"Whole-Exome Sequencing of Pancreatic Cancer Defines Genetic Diversity and Therapeutic Targets","volume":"6","author":"Witkiewicz","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00018-006-6005-y","article-title":"Back to the Roots: The Remarkable RAF Oncogene Story","volume":"63","author":"Zebisch","year":"2006","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1158\/2159-8290.CD-11-0347","article-title":"A Central Role for RAF\u2192MEK\u2192ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma","volume":"2","author":"Collisson","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4161\/cc.9.3.10599","article-title":"Hot-Spot Mutations in P110alpha of Phosphatidylinositol 3-Kinase (pI3K): Differential Interactions with the Regulatory Subunit P85 and with RAS","volume":"9","author":"Zhao","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/modpathol.2017.60","article-title":"Pancreatic Intraductal Tubulopapillary Neoplasm Is Genetically Distinct from Intraductal Papillary Mucinous Neoplasm and Ductal Adenocarcinoma","volume":"30","author":"Basturk","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.4242","article-title":"The Discrete Nature and Distinguishing Molecular Features of Pancreatic Intraductal Tubulopapillary Neoplasms and Intraductal Papillary Mucinous Neoplasms of the Gastric Type, Pyloric Gland Variant","volume":"231","author":"Yamaguchi","year":"2013","journal-title":"J. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1038\/oncsis.2015.28","article-title":"PIK3CA Mutations Can Initiate Pancreatic Tumorigenesis and Are Targetable with PI3K Inhibitors","volume":"4","author":"Payne","year":"2015","journal-title":"Oncogenesis"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/modpathol.3880547","article-title":"C-MYC Activation in Primary and Metastatic Ductal Adenocarcinoma of the Pancreas: Incidence, Mechanisms, and Clinical Significance","volume":"15","author":"Schleger","year":"2002","journal-title":"Mod. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00428-014-1657-8","article-title":"Acinar Cell Carcinomas of the Pancreas: A Molecular Analysis in a Series of 57 Cases","volume":"465","author":"Bergmann","year":"2014","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/0008-5472.CAN-18-1968","article-title":"PIN1 Maintains Redox Balance via the C-Myc\/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells","volume":"79","author":"Liang","year":"2019","journal-title":"Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11914-015-0268-x","article-title":"GNAS Spectrum of Disorders","volume":"13","author":"Turan","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrc3521","article-title":"The Emerging Mutational Landscape of G Proteins and G-Protein-Coupled Receptors in Cancer","volume":"13","author":"Kufareva","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"92ra66","DOI":"10.1126\/scitranslmed.3002543","article-title":"Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development","volume":"3","author":"Wu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPA.0000000000000253","article-title":"Molecular Biomarkers for Progression of Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"44","author":"Kuboki","year":"2015","journal-title":"Pancreas"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/srep00161","article-title":"Whole-Exome Sequencing Uncovers Frequent GNAS Mutations in Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"1","author":"Furukawa","year":"2011","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tcb.2008.01.008","article-title":"LKB1 and AMPK in Cell Polarity and Division","volume":"18","author":"Williams","year":"2008","journal-title":"Trends Cell Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/1078-0432.CCR-06-0083","article-title":"Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome","volume":"12","author":"Hearle","year":"2006","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gutjnl-2018-318059","article-title":"Kras and Lkb1 Mutations Synergistically Induce Intraductal Papillary Mucinous Neoplasm Derived from Pancreatic Duct Cells","volume":"69","author":"Collet","year":"2020","journal-title":"Gut"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0002-9440(10)63053-2","article-title":"STK11\/LKB1 Peutz-Jeghers Gene Inactivation in Intraductal Papillary-Mucinous Neoplasms of the Pancreas","volume":"159","author":"Sato","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma","volume":"32","author":"Raphael","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/0008-5472.CAN-24-2330","article-title":"SMAD4 and KRAS Status Shapes Cancer Cell-Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer","volume":"85","author":"Lloyd","year":"2025","journal-title":"Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular Alterations and Targeted Therapy in Pancreatic Ductal Adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-Induced JAK\/STAT Signaling Is Antagonized by TGF\u03b2 to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2009.10.015","article-title":"The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors","volume":"16","author":"Hedvat","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00280-019-03931-1","article-title":"Population Pharmacokinetics and Exposure-Overall Survival Analysis of the Transforming Growth Factor-\u03b2 Inhibitor Galunisertib in Patients with Pancreatic Cancer","volume":"84","author":"Gueorguieva","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"117472","DOI":"10.1016\/j.cca.2023.117472","article-title":"MicroRNA Electrochemical Biosensors for Pancreatic Cancer","volume":"548","author":"Rahdan","year":"2023","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MPA.0000000000000368","article-title":"Early Detection of Sporadic Pancreatic Cancer: Summative Review","volume":"44","author":"Chari","year":"2015","journal-title":"Pancreas"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4137\/BMI.S27679","article-title":"miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review","volume":"10","author":"Alemar","year":"2015","journal-title":"Biomark. Insights"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Jin, X., Sun, Y., Yang, H., Li, J., Yu, S., Chang, X., Lu, Z., and Chen, J. (2015). Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125515"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"109424","DOI":"10.1016\/j.biopha.2019.109424","article-title":"MiR-143-3p Suppresses Tumorigenesis in Pancreatic Ductal Adenocarcinoma by Targeting KRAS","volume":"119","author":"Xie","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41419-018-1182-9","article-title":"miR-21 Promotes EGF-Induced Pancreatic Cancer Cell Proliferation by Targeting Spry2","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s12094-022-02991-9","article-title":"Tumor-Suppressive miR-29c Binds to MAPK1 Inhibiting the ERK\/MAPK Pathway in Pancreatic Cancer","volume":"25","author":"Si","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"ref_101","first-page":"130","article-title":"Downregulated miR-98-5p Promotes PDAC Proliferation and Metastasis by Reversely Regulating MAP4K4","volume":"37","author":"Fu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.18632\/oncotarget.3686","article-title":"miR-221\/222 Induces Pancreatic Cancer Progression through the Regulation of Matrix Metalloproteinases","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12935-022-02835-0","article-title":"Increased Expression of miR-194-5p through the circPVRL3\/miR-194-5p\/SOCS2 Axis Promotes Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma by Activating the PI3K\/AKT Signaling Pathway","volume":"22","author":"Chi","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41419-021-03576-0","article-title":"miR-30d Suppresses Proliferation and Invasiveness of Pancreatic Cancer by Targeting the SOX4\/PI3K-AKT Axis and Predicts Poor Outcome","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.omtn.2019.06.015","article-title":"Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer","volume":"17","author":"Ginesta","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 Family and miR-205 Regulate Epithelial to Mesenchymal Transition by Targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41419-018-0839-8","article-title":"MiR-361-3p Regulates ERK1\/2-Induced EMT via DUSP2 mRNA Degradation in Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Hu","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Huang, W., Gu, J., Tao, T., Zhang, J., Wang, H., and Fan, Y. (2019). MiR-24-3p Inhibits the Progression of Pancreatic Ductal Adenocarcinoma Through LAMB3 Downregulation. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01499"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10528-022-10278-5","article-title":"miR-24-3p Regulates Epithelial-Mesenchymal Transition and the Malignant Phenotype of Pancreatic Adenocarcinoma by Regulating ASF1B Expression","volume":"61","author":"Huang","year":"2023","journal-title":"Biochem. Genet."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3748\/wjg.v26.i19.2349","article-title":"MiR-301a Transcriptionally Activated by HIF-2\u03b1 Promotes Hypoxia-Induced Epithelial-Mesenchymal Transition by Targeting TP63 in Pancreatic Cancer","volume":"26","author":"Zhang","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.7150\/ijbs.67675","article-title":"Hypoxic Pancreatic Cancer Derived Exosomal miR-30b-5p Promotes Tumor Angiogenesis by Inhibiting GJA1 Expression","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_112","first-page":"310","article-title":"Macrophage-Derived Exosomal microRNA-501-3p Promotes Progression of Pancreatic Ductal Adenocarcinoma through the TGFBR3-Mediated TGF-\u03b2 Signaling Pathway","volume":"38","author":"Yin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00280-021-04289-z","article-title":"MiRNA-3662 Reverses the Gemcitabine Resistance in Pancreatic Cancer through Regulating the Tumor Metabolism","volume":"88","author":"Liu","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1159\/000494477","article-title":"miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism","volume":"50","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/pin.13289","article-title":"Tumor-Suppressive miR-323a Inhibits Pancreatic Cancer Cell Proliferation and Glycolysis through Targeting HK-2","volume":"72","author":"Wei","year":"2022","journal-title":"Pathol. Int."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1158\/1541-7786.MCR-19-0594","article-title":"miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2","volume":"18","author":"Dey","year":"2020","journal-title":"Mol. Cancer Res. MCR"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2016.11.030","article-title":"Current Status of Biomarker and Targeted Nanoparticle Development: The Precision Oncology Approach for Pancreatic Cancer Therapy","volume":"388","author":"Zhu","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_118","first-page":"3862","article-title":"Mesothelin Is Overexpressed in the Vast Majority of Ductal Adenocarcinomas of the Pancreas: Identification of a New Pancreatic Cancer Marker by Serial Analysis of Gene Expression (SAGE)","volume":"7","author":"Argani","year":"2001","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Brassart-Pasco, S., Br\u00e9zillon, S., Brassart, B., Ramont, L., Oudart, J.-B., and Monboisse, J.C. (2020). Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00397"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Procacci, P., Moscheni, C., Sartori, P., Sommariva, M., and Gagliano, N. (2018). Tumor\u2013Stroma Cross-Talk in Human Pancreatic Ductal Adenocarcinoma: A Focus on the Effect of the Extracellular Matrix on Tumor Cell Phenotype and Invasive Potential. Cells, 7.","DOI":"10.3390\/cells7100158"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s000180050497","article-title":"The Plasminogen Activation System in Tumor Growth, Invasion, and Metastasis","volume":"57","author":"Andreasen","year":"2000","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Kumar, A.A., Buckley, B.J., and Ranson, M. (2022). The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets. Biomolecules, 12.","DOI":"10.3390\/biom12020152"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1016\/S0021-9258(18)98900-3","article-title":"Inhibition of Cell Surface Receptor-Bound Plasmin by Alpha 2-Antiplasmin and Alpha 2-Macroglobulin","volume":"266","author":"Hall","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1158\/0008-5472.CAN-09-1636","article-title":"Inhibition of the P38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells","volume":"69","author":"Chen","year":"2009","journal-title":"Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1023\/A:1026122421369","article-title":"Coexpression of IGF-1R and c-Src Proteins in Human Pancreatic Ductal Adenocarcinoma","volume":"48","author":"Hakam","year":"2003","journal-title":"Dig. Dis. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/187152011795677454","article-title":"Insulin-like growth factor signaling as a therapeutic target in pancreatic cancer","volume":"11","author":"Rieder","year":"2011","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2613.2002.00237.x","article-title":"Serum and Tissue Level of Insulin-like Growth Factor-I (IGF-I) and IGF-I Binding Proteins as an Index of Pancreatitis and Pancreatic Cancer","volume":"83","author":"Karna","year":"2002","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_128","first-page":"2007","article-title":"Insulin-like Growth Factor I Overexpression in Human Pancreatic Cancer: Evidence for Autocrine and Paracrine Roles","volume":"55","author":"Bergmann","year":"1995","journal-title":"Cancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3748\/wjg.v16.i15.1854","article-title":"Insulin-like Growth Factor-I Receptor in Proliferation and Motility of Pancreatic Cancer","volume":"16","author":"Tomizawa","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.bjc.6605932","article-title":"Insulin-like Growth Factors and Insulin Control a Multifunctional Signalling Network of Significant Importance in Cancer","volume":"103","author":"Massoner","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most Human Carcinomas of the Exocrine Pancreas Contain Mutant C-K-Ras Genes","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/1541-7786.MCR-12-0340-T","article-title":"KRAS(G12D)- and BRAF(V600E)-Induced Transformation of Murine Pancreatic Epithelial Cells Requires MEK\/ERK-Stimulated IGF1R Signaling","volume":"10","author":"Appleman","year":"2012","journal-title":"Mol. Cancer Res. MCR"},{"key":"ref_133","first-page":"589","article-title":"AKT Activation Up-Regulates Insulin-like Growth Factor I Receptor Expression and Promotes Invasiveness of Human Pancreatic Cancer Cells","volume":"61","author":"Tanno","year":"2001","journal-title":"Cancer Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/cancers3021513","article-title":"Epidermal Growth Factor Receptor in Pancreatic Cancer","volume":"3","author":"Newman","year":"2011","journal-title":"Cancers"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1002\/cncr.26661","article-title":"Epidermal Growth Factor Receptor and Insulinlike Growth Factor 1 Receptor Expression Predict Poor Survival in Pancreatic Ductal Adenocarcinoma","volume":"118","author":"Valsecchi","year":"2012","journal-title":"Cancer"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.2147\/IJN.S226628","article-title":"Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles","volume":"14","author":"Grapa","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Perez, S.M., Brinton, L.T., and Kelly, K.A. (2021). Plectin in Cancer: From Biomarker to Therapeutic Target. Cells, 10.","DOI":"10.3390\/cells10092246"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Kelly, K.A., Bardeesy, N., Anbazhagan, R., Gurumurthy, S., Berger, J., Alencar, H., Depinho, R.A., Mahmood, U., and Weissleder, R. (2008). Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050085"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1158\/1078-0432.CCR-10-0999","article-title":"Plectin-1 as a Novel Biomarker for Pancreatic Cancer","volume":"17","author":"Bausch","year":"2011","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/sj.bjc.6604677","article-title":"High Expression of TROP2 Correlates with Poor Prognosis in Pancreatic Cancer","volume":"99","author":"Fong","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_141","first-page":"103","article-title":"Expression and clinical significance of Trop-2 in human pancreatic cancer","volume":"91","author":"Qiu","year":"2011","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/onc.2012.151","article-title":"The Trop-2 Signalling Network in Cancer Growth","volume":"32","author":"Guerra","year":"2013","journal-title":"Oncogene"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1476-4598-9-253","article-title":"Trop2 Expression Contributes to Tumor Pathogenesis by Activating the ERK MAPK Pathway","volume":"9","author":"Cubas","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1158\/1078-0432.CCR-15-1701","article-title":"Trop-2 Induces Tumor Growth Through AKT and Determines Sensitivity to AKT Inhibitors","volume":"22","author":"Guerra","year":"2016","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.18632\/oncotarget.27299","article-title":"Correction: TROP2 Promotes Proliferation, Migration and Metastasis of Gallbladder Cancer Cells by Regulating PI3K\/AKT Pathway and Inducing EMT","volume":"10","author":"Li","year":"2019","journal-title":"Oncotarget"},{"key":"ref_146","first-page":"30","article-title":"Nectin-4 Expression Contributes to Tumor Proliferation, Angiogenesis and Patient Prognosis in Human Pancreatic Cancer","volume":"34","author":"Nishiwada","year":"2015","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"20250007","DOI":"10.1002\/VIW.20250007","article-title":"Nectin4-Targeted Molecular Imaging in Solid Tumors: Current Status and Future Perspectives","volume":"6","author":"Liu","year":"2025","journal-title":"View"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1242\/jcs.024620","article-title":"Involvement of the Nectin-Afadin Complex in PDGF-Induced Cell Survival","volume":"121","author":"Kanzaki","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving Cognition of the JAK-STAT Signaling Pathway: Autoimmune Disorders and Cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e000266","DOI":"10.1136\/jitc-2019-000266","article-title":"Nectin4 Is a Novel TIGIT Ligand Which Combines Checkpoint Inhibition and Tumor Specificity","volume":"8","author":"Reches","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1369\/0022155411420569","article-title":"Claudin-18 Is an Early-Stage Marker of Pancreatic Carcinogenesis","volume":"59","author":"Tanaka","year":"2011","journal-title":"J. Histochem. Cytochem. Off. J. Histochem. Soc."},{"key":"ref_152","first-page":"971","article-title":"Immunohistochemical Analysis of Claudin Expression in Pancreatic Cystic Tumors","volume":"25","author":"Lee","year":"2011","journal-title":"Oncol. Rep."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jclinpath-2011-200400","article-title":"Expression of Claudins 7 and 18 in Pancreatic Ductal Adenocarcinoma: Association with Features of Differentiation","volume":"65","author":"Soini","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/jcb.23095","article-title":"Transcriptional Regulation of Claudin-18 via Specific Protein Kinase C Signaling Pathways and Modification of DNA Methylation in Human Pancreatic Cancer Cells","volume":"112","author":"Ito","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.21037\/tcr-19-1876","article-title":"Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer","volume":"9","author":"Hong","year":"2020","journal-title":"Transl. Cancer. Res."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Hoareau-Aveilla, C., and Meggetto, F. (2017). Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive Lymphomas. Cancers, 9.","DOI":"10.3390\/cancers9080100"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ijc.28400","article-title":"Claudin 18.2 Is a Target for IMAB362 Antibody in Pancreatic Neoplasms","volume":"134","author":"Schlitter","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"16735","DOI":"10.1038\/s41598-019-53130-4","article-title":"Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer","volume":"9","author":"Zhu","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"106954","DOI":"10.1016\/j.crad.2025.106954","article-title":"Imaging Pancreatic Cancer with [18F]F-AlF-NOTA-FAPI-04 Positron Emission Tomography\/Computed Tomography (PET\/CT): Distribution Patterns and Therapeutic Implications","volume":"87","author":"Wang","year":"2025","journal-title":"Clin. Radiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1007\/s00259-025-07271-6","article-title":"[18F]FAPI- 04 PET\/CT for Pathologic Response Assessment in Pancreatic Cancer Patients with Systemic Treatment","volume":"52","author":"Li","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Qiu, L., Chen, Y., Ketcherside, T., Wang, Z., DeWees, T., Williams, T.M., Amini, A., Sampath, S., Glaser, S., and Chen, Y.-J. (2025). Comparative Evaluation of [68Ga]Ga-Fibroblast Activation Protein Inhibitor vs. [18F]FDG as a Novel Radiotracer for Biology-Guided Image Radiotherapy. Cancers, 17.","DOI":"10.3390\/cancers17223648"},{"key":"ref_162","first-page":"1903","article-title":"68Ga-FAPI PET\/CT Prevents Futile Surgery and Demonstrates Tumor Biology in Patients with Pancreatic Ductal Adenocarcinoma","volume":"66","author":"McGahan","year":"2025","journal-title":"J. Nucl. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00259-024-06943-z","article-title":"Preoperative Assessment of Pancreatic Cancer with [68Ga]Ga-DOTA-FAPI-04 PET\/MR versus [18F]-FDG PET\/CT plus Contrast-Enhanced CT: A Prospective Preliminary Study","volume":"52","author":"Zhang","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12967-024-04958-6","article-title":"Autophagy Inhibition Improves the Targeted Radionuclide Therapy Efficacy of 131I-FAP-2286 in Pancreatic Cancer Xenografts","volume":"22","author":"Liu","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Li, Y., Zhao, H., Hu, S., Zhang, X., Chen, H., and Zheng, Q. (2023). PET Imaging with [68Ga]-Labeled TGF\u03b2-Targeting Peptide in a Mouse PANC-1 Tumor Model. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1228281"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00259-024-06617-w","article-title":"Magnetic-Optical Dual-Modality Imaging Monitoring Chemotherapy Efficacy of Pancreatic Ductal Adenocarcinoma with a Low-Dose Fibronectin-Targeting Gd-Based Contrast Agent","volume":"51","author":"Zhang","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1021\/acs.jmedchem.5c01189","article-title":"Design, Synthesis, and Biological Evaluation of [18F]AlF-Labeled Integrin Av\u03b26-Targeting Tracers for Pancreatic Cancer Imaging","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1021\/acs.molpharmaceut.5c00051","article-title":"Preclinical Evaluation and First-in-Human Study of [68Ga]Ga-Av\u03b26-2: A Novel Dimeric Integrin Av\u03b26-Targeted PET Probe for Pancreatic Cancer Imaging","volume":"22","author":"Pang","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2967\/jnumed.122.264749","article-title":"Preclinical Evaluation of 68Ga- and 177Lu-Labeled Integrin Av\u03b26-Targeting Radiotheranostic Peptides","volume":"64","author":"Ganguly","year":"2023","journal-title":"J. Nucl. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00259-021-05595-7","article-title":"Pilot-Phase PET\/CT Study Targeting Integrin Av\u03b26 in Pancreatic Cancer Patients Using the Cystine-Knot Peptide-Based 18F-FP-R01-MG-F2","volume":"50","author":"Nakamoto","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Sachindra, S., Hellberg, T., Exner, S., Prasad, S., Beindorff, N., Rogalla, S., Kimura, R., Gambhir, S.S., Wiedenmann, B., and Gr\u00f6tzinger, C. (2021). SPECT\/CT Imaging, Biodistribution and Radiation Dosimetry of a 177Lu-DOTA-Integrin Av\u03b26 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.684713"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.7150\/jca.51190","article-title":"Preliminary Study on SPECT\/CT Imaging of Pancreatic Cancer Xenografts by Targeting Integrin A5 in Pancreatic Stellate Cells","volume":"12","author":"Wang","year":"2021","journal-title":"J. Cancer"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1021\/acs.molpharmaceut.3c00321","article-title":"Automated Synthesis and Preclinical Evaluation of Optimized Integrin A6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer","volume":"20","author":"Chen","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1021\/jacs.3c11666","article-title":"Targeted Cyclo[8]Pyrrole-Based NIR-II Photoacoustic Tomography Probe for Suppression of Orthotopic Pancreatic Tumor Growth and Intra-Abdominal Metastases","volume":"146","author":"Chen","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Jin, X., Dong, C., Zheng, K., Shi, X., Liu, Y., Huo, L., Wang, F., and Li, F. (2021). Scintigraphic Imaging of Neovascularization With 99mTc-3PRGD2 for Evaluating Early Response to Endostar Involved Therapies on Pancreatic Cancer Xenografts In Vivo. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.792431"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"108364","DOI":"10.1016\/j.nucmedbio.2023.108364","article-title":"Integrin Av\u03b23 and EGFR Dual-Targeted [64Cu]Cu-NOTA-RGD-GE11 Heterodimer for PET Imaging in Pancreatic Cancer Mouse Model","volume":"124\u2013125","author":"Li","year":"2023","journal-title":"Nucl. Med. Biol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Xiang, Q., Li, D., Cheng, C., Xu, K., and Zuo, C. (2023). 68Ga-HBED-CC-WL-12 PET in Diagnosing and Differentiating Pancreatic Cancers in Murine Models. Pharmaceuticals, 16.","DOI":"10.3390\/ph16010080"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"e2302195","DOI":"10.1002\/adhm.202302195","article-title":"Multimodal Imaging-Guided Photoimmunotherapy of Pancreatic Cancer by Organosilica Nanomedicine","volume":"13","author":"Zhang","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1021\/acs.molpharmaceut.5c00072","article-title":"Construction of Bispecific T-Cell Engager Radiotracer and Its Micro-PET Evaluation in Pancreatic Cancer","volume":"22","author":"Wen","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1021\/acs.molpharmaceut.3c00311","article-title":"ImmunoPET Imaging of CD47 with VHH-Derived Tracers in Pancreatic Cancers","volume":"20","author":"Liang","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"217713","DOI":"10.1016\/j.canlet.2025.217713","article-title":"CD44 Identified as a Diagnostic Biomarker for Highly Malignant CA19-9 Negative Pancreatic Cancer","volume":"622","author":"Tang","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00259-023-06115-5","article-title":"An Ultra-Small Bispecific Protein Augments Tumor Penetration and Treatment for Pancreatic Cancer","volume":"50","author":"Wang","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00259-021-05563-1","article-title":"ImmunoPET of Trophoblast Cell-Surface Antigen 2 (Trop-2) Expression in Pancreatic Cancer","volume":"49","author":"Chen","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00259-022-05954-y","article-title":"Theranostic Application of 64Cu\/177Lu-Labeled Anti-Trop2 Monoclonal Antibody in Pancreatic Cancer Tumor Models","volume":"50","author":"Li","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Matsumoto, H., Watabe, T., Igarashi, C., Tachibana, T., Hihara, F., Waki, A., Zhang, M.-R., Tashima, H., Yamaya, T., and Ooe, K. (2021). Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates. Pharmaceuticals, 14.","DOI":"10.3390\/ph14100950"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Matsumoto, H., Igarashi, C., Tachibana, T., Hihara, F., Waki, A., Zhang, M.-R., Yoshida, S., Naito, K., Kurihara, H., and Ueno, M. (2021). Characterization and Stabilization of a New 64Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010067"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2967\/jnumed.120.256776","article-title":"Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer","volume":"62","author":"Henry","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nucmedbio.2022.02.003","article-title":"Radiation Dosimetry and Efficacy of an 89Zr\/225Ac-Labeled Humanized Anti-MUC5AC Antibody","volume":"108\u2013109","author":"Nakata","year":"2022","journal-title":"Nucl. Med. Biol."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Jaiswal, S., Amirfakhri, S., Bravo, J., Kobayashi, K., Aithal, A., Talib, S., Mallya, K., Jain, M., Mohs, A.M., and Hoffman, R.M. (2025). Mucin4 (MUC4) Antibody Labeled with an NIR Dye Brightly Targets Pancreatic Cancer Liver Metastases and Peritoneal Carcinomatosis. Cancers, 17.","DOI":"10.3390\/cancers17122031"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.62347\/VFHT4078","article-title":"[99mTc]Tc-Labeled Cyc-DX600-HYNIC as a SPECT Probe for ACE2-Specific Pancreatic Cancer Imaging","volume":"14","author":"Zhou","year":"2024","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.7150\/thno.106948","article-title":"EphA2-Targeted Alpha-Particle Theranostics for Enhancing PDAC Treatment","volume":"15","author":"Sharma","year":"2025","journal-title":"Theranostics"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00259-025-07441-6","article-title":"ImmunoPET Imaging of C-Met Using a Nanobody-Based Tracer [68Ga]Ga-NOTA-PFCM01 in Pancreatic Ductal Adenocarcinoma Models and Non-Human Primates","volume":"53","author":"Sun","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"23335","DOI":"10.1021\/acs.jmedchem.5c02187","article-title":"Preclinical Evaluation of 68Ga-Labeled CSPG4-Targeting Peptides for PET\/CT Imaging in Pancreatic and Gastric Carcinoma","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.7150\/jca.69710","article-title":"18F-Labeled Dimer-Sansalvamide A Cyclodecapeptide: A Novel Diagnostic Probe to Discriminate Pancreatic Cancer from Inflammation in a Nude Mice Model","volume":"13","author":"Wang","year":"2022","journal-title":"J. Cancer"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"18519","DOI":"10.1021\/acs.jmedchem.5c01304","article-title":"Development and Evaluation of [68Ga]Ga-DOTA-BT1718: A Novel Imaging Agent Targeting MT1-MMP for Malignant Tumor Diagnosis","volume":"68","author":"Yang","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"108085","DOI":"10.1016\/j.bioorg.2024.108085","article-title":"First-Generation High-Affinity ST14 Radiopharmaceutical: Design, Synthesis, and Preclinical PET Imaging Evaluation for Pancreatic Cancer Detection","volume":"154","author":"Peng","year":"2025","journal-title":"Bioorganic Chem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1021\/acs.molpharmaceut.5c00430","article-title":"Development of [18F]AlF-RESCA-H006 as a Novel Molecular Probe for 5T4 Tumor Imaging and Exploration of Its Application in Pancreatic Adenocarcinoma","volume":"22","author":"Kong","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Gao, J., Wang, Y., Wang, R., Liu, M., Wang, H., Li, J., and Du, J. (2025). Preclinical Studies of a PARP-Targeted Theranostic Radiopharmaceutical for Pancreatic Cancer. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1576587"},{"key":"ref_199","unstructured":"Patel, J.S., Zhou, X., Chen, J., Gao, Y., Zhao, C., Song, Z., Zhao, T., Hu, Q., Li, X., and Li, C. (2025). A Novel 18 F-Labeled Brain Penetrant PET Ligand for Imaging Poly(ADP-Ribose) Polymerase-1. BioRxiv."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Luo, T., Zhang, K., Wu, C., Wu, X., Yang, H., Chen, Z., and Jiang, F. (2025). Preclinical Evaluation of uPAR-ICG-FVIOs for Dual-Mode Imaging and Magnetic Hyperthermia Therapy in Pancreatic Cancer. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1681718"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2967\/jnumed.124.268278","article-title":"uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence","volume":"65","author":"Pratt","year":"2024","journal-title":"J. Nucl. Med."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1111\/cas.15846","article-title":"Novel Positron Emission Tomography Imaging Targeting Cell Surface Glycans for Pancreatic Cancer: 18 F-Labeled rBC2LCN Lectin","volume":"114","author":"Kuroda","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1021\/acs.molpharmaceut.4c00082","article-title":"KRAS Mutation Detection with (2S,4R)-4-[18F]FGln for Noninvasive PDAC Diagnosis","volume":"21","author":"Liu","year":"2024","journal-title":"Mol. Pharm."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Potemkin, R., Maschauer, S., H\u00fcbner, H., Kuwert, T., B\u00e4uerle, T., Gmeiner, P., and Prante, O. (2025). 99mTc-Labeled Diarylpyrazoles for Single-Emission Computer Tomography Imaging of Neurotensin Receptor-Positive Tumors: A Comparative Preclinical Study. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17060700"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1021\/acs.analchem.3c01765","article-title":"Novel GRPR-Targeting Peptide for Pancreatic Cancer Molecular Imaging in Orthotopic and Liver Metastasis Mouse Models","volume":"95","author":"Tu","year":"2023","journal-title":"Anal. Chem."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"34965","DOI":"10.1021\/acsami.5c01194","article-title":"Ultrasound-Triggered NPC1L1-Targeting Nanobubbles for Remodeling the Tumor Microenvironment in Pancreatic Cancer Chemoimmunotherapy","volume":"17","author":"Dong","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1021\/acs.jmedchem.3c00753","article-title":"Site-Specific Conjugation of 6 DOTA Chelators to a CA19-9-Targeting scFv-Fc Antibody for Imaging and Therapy","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Cox, K.E., Bravo, J., Jaiswal, S., Amirfakhri, S., Lwin, T.M., Aithal, A., Talib, S., Jih, L.J., Saleh, A.D.P., and Kobayashi, K. (2025). Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a Near-Infrared Fluorophore. Cancers, 17.","DOI":"10.3390\/cancers17162617"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"van Manen, L., de Muynck, L.D.A.N., Baart, V.M., Bhairosingh, S., Debie, P., Vahrmeijer, A.L., Hernot, S., and Mieog, J.S.D. (2023). Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study. Biomolecules, 13.","DOI":"10.3390\/biom13040618"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1158\/2767-9764.CRC-24-0244","article-title":"Intraoperative Guidance of Pancreatic Cancer Resection Using a Toll-like Receptor 2-Targeted Fluorescence Molecular Imaging Agent","volume":"4","author":"Huynh","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11307-025-02024-1","article-title":"One-Step Radiosynthesis and Preclinical Evaluation of Molecular Tracer [18F]FEtO-CHC Targeting Monocarboxylate Transporters for PET Imaging in Tumor-Bearing Mice","volume":"27","author":"Shi","year":"2025","journal-title":"Mol. Imaging Biol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"17348","DOI":"10.1021\/acsnano.1c05165","article-title":"Imaging Strategy That Achieves Ultrahigh Contrast by Utilizing Differential Esterase Activity in Organs: Application in Early Detection of Pancreatic Cancer","volume":"15","author":"Lee","year":"2021","journal-title":"ACS Nano"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Takahashi, R., Ishizawa, T., Sato, M., Inagaki, Y., Takanka, M., Kuriki, Y., Kamiya, M., Ushiku, T., Urano, Y., and Hasegawa, K. (2021). Fluorescence Imaging Using Enzyme-Activatable Probes for Real-Time Identification of Pancreatic Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.714527"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00259-025-07432-7","article-title":"Lysosome-Escaping and Nucleus-Targeting Nanomedicine for Enhanced Cancer Catalytic Internal Radiotherapy","volume":"53","author":"Su","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"e2408527","DOI":"10.1002\/smll.202408527","article-title":"A Self-Calibrating Fluorescent-Photoacoustic Integrated Probe Enables Fast Visualizing Pancreatic Cancer and Imaging-Guided Tumor Surgery","volume":"21","author":"Hu","year":"2025","journal-title":"Small"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1021\/acsnanoscienceau.5c00010","article-title":"Cellular Uptake of Hybrid PLGA-Lipid Gadolinium Nanoparticles Functionalized for Magnetic Resonance Imaging of Pancreatic Adenocarcinoma Cells","volume":"5","author":"Amaolo","year":"2025","journal-title":"ACS Nanosci. AU"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3753","article-title":"Epigenomic Reprogramming during Pancreatic Cancer Progression Links Anabolic Glucose Metabolism to Distant Metastasis","volume":"49","author":"McDonald","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM Procedure Guidelines for Tumour Imaging: Version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2967\/jnumed.124.269425","article-title":"Summary Report of the SNMMI AI Task Force Radiomics Challenge 2024","volume":"66","author":"Boellaard","year":"2025","journal-title":"J. Nucl. Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1007\/s00261-024-04775-x","article-title":"AI-Driven Insights in Pancreatic Cancer Imaging: From Pre-Diagnostic Detection to Prognostication","volume":"50","author":"Antony","year":"2025","journal-title":"Abdom. Radiol."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Li, Y.-R., Li, D., Zhou, Y.-W., Wang, W.-E., Ma, Y.-S., Liu, X.-Y., Yang, Q.-X., Lu, C.-N., Cai, Y.-F., and Yang, C. (2026). Artificial Intelligence-Driven Early Screening and Diagnosis of Pancreatic Cancer: Technical Innovations, Clinical Applications, and Precision Medicine Strategies. J. Adv. Res.","DOI":"10.1016\/j.jare.2026.04.060"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/ibd\/izac115","article-title":"A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation","volume":"28","author":"Stafford","year":"2022","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"\u015eahin, E., and Tatar, O.C. (2026). Multimodal AI Approach Combining Deep Learning Imaging and Clinical Machine Learning for Pancreatic Cancer Detection. Updat. Surg., 1\u20139.","DOI":"10.1007\/s13304-026-02650-6"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1245\/s10434-018-6453-2","article-title":"Intraoperative Pancreatic Cancer Detection Using Tumor-Specific Multimodality Molecular Imaging","volume":"25","author":"Tummers","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","article-title":"Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach","volume":"14","author":"Cheng","year":"2020","journal-title":"ACS Nano"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7150\/thno.64805","article-title":"Nanocarriers for Pancreatic Cancer Imaging, Treatments, and Immunotherapies","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.2147\/IJN.S548825","article-title":"Strategies for Pancreatic Cancer-Responsive Nanodrug Platforms Targeting Tumor Hypoxic Environments","volume":"20","author":"Joo","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Chow, J.C.L. (2025). Nanomaterial-Based Molecular Imaging in Cancer: Advances in Simulation and AI Integration. Biomolecules, 15.","DOI":"10.3390\/biom15030444"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41575-021-00470-0","article-title":"Early Detection of Pancreatic Cancer Using DNA-Based Molecular Approaches","volume":"18","author":"Singhi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/1078\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:12:05Z","timestamp":1784175125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/1078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":229,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ph19071078"],"URL":"https:\/\/doi.org\/10.3390\/ph19071078","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}